Tag: Gene Therapy
Medicare to Cover CAR-T Therapy for Leukemia, Lymphoma
Chimeric antigen receptor T-cell therapy boosts a patient's own immune cells
FDA: Approval of Zolgensma Was Based on Manipulated Data
Despite inaccurate data, FDA says it is 'confident that Zolgensma should remain on the market'
Lifesaving Drug for Infants Costs $2.1 Million a Dose
When Zolgensma was approved, maker Novartis said it expected insurance companies to cover the cost
FDA Approves First Gene Therapy for Spinal Muscular Atrophy
Patients treated with Zolgensma have shown improvement in reaching developmental motor milestones
Gene Therapy Forms New Polysynaptic Pathways in Parkinson’s
Patients receiving GAD gene therapy develop unique treatment-dependent polysynaptic brain circuit
Potential First U.S. Gene Therapy Now Under FDA Review
Tisagenlecleucel could be a one-time treatment for children and young adults with advanced leukemia
Gene Tx May Benefit Children, Teens With Wiskott-Aldrich Sx
Patient's own blood stem cells are removed to correct the WAS gene, then injected back into the patient
